Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Makaira Partners LLC

Makaira Partners LLC cut its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 1.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,262,506 shares of the company's stock after selling 40,200 shares during the period. Bath & Body Works makes up 12.2% of Makaira Partners LLC's portfolio, making the stock its 3rd largest holding. Makaira Partners LLC owned about 1.04% of Bath & Body Works worth $87,717,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. SRS Capital Advisors Inc. boosted its position in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after buying an additional 329 shares during the period. Golden State Wealth Management LLC purchased a new stake in Bath & Body Works in the 4th quarter valued at about $26,000. UMB Bank n.a. boosted its position in Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after buying an additional 335 shares during the period. Lindbrook Capital LLC boosted its position in Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after buying an additional 431 shares during the period. Finally, Smartleaf Asset Management LLC boosted its position in Bath & Body Works by 135.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock valued at $39,000 after buying an additional 582 shares during the period. 95.14% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have issued reports on BBWI. Cowen reissued a "buy" rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Telsey Advisory Group reissued an "outperform" rating and issued a $43.00 price objective on shares of Bath & Body Works in a research report on Thursday, February 27th. JPMorgan Chase & Co. lowered their price target on shares of Bath & Body Works from $47.00 to $41.00 and set an "overweight" rating for the company in a research report on Monday, April 14th. Citigroup cut their price objective on shares of Bath & Body Works from $48.00 to $36.00 and set a "buy" rating on the stock in a report on Monday, April 7th. Finally, Barclays lowered their target price on Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating for the company in a report on Monday, March 3rd. Four research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $42.19.

Bath & Body Works Stock Down 1.6 %

Shares of Bath & Body Works stock traded down $0.50 during trading on Thursday, reaching $30.02. The company's stock had a trading volume of 3,911,398 shares, compared to its average volume of 4,798,116. The company has a market cap of $6.39 billion, a price-to-earnings ratio of 7.32, a P/E/G ratio of 0.92 and a beta of 1.69. Bath & Body Works, Inc. has a 1-year low of $24.96 and a 1-year high of $52.99. The company has a 50-day simple moving average of $30.80 and a two-hundred day simple moving average of $33.81.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $2.79 billion during the quarter, compared to analysts' expectations of $2.78 billion. As a group, analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were issued a $0.20 dividend. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 annualized dividend and a dividend yield of 2.67%. Bath & Body Works's dividend payout ratio (DPR) is presently 21.98%.

Bath & Body Works declared that its Board of Directors has initiated a stock buyback plan on Thursday, February 27th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to buy up to 6.4% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's leadership believes its stock is undervalued.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.